Symbol="RPHM"
AssetType="Common Stock"
Name="Reneo Pharmaceuticals Inc"
Description="Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. The company is headquartered in San Diego, California."
CIK="1637715"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="18575 JAMBOREE ROAD, SUITE 275-S, IRVINE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="200937000"
EBITDA="-56846000"
PERatio="None"
PEGRatio="None"
BookValue="3.468"
DividendPerShare="0"
DividendYield="0"
EPS="-1.96"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.293"
ReturnOnEquityTTM="-0.486"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.96"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="25.86"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.469"
EVToRevenue="-"
EVToEBITDA="1.249"
Beta="1.005"
num_52WeekHigh="11.29"
num_52WeekLow="1.79"
num_50DayMovingAverage="7.51"
num_200DayMovingAverage="4.949"
SharesOutstanding="33657800"
DividendDate="None"
ExDividendDate="None"
symbol="RPHM"
open="6.01"
high="6.35"
low="5.85"
price="5.97"
volume="148434.00"
latest_trading_day="2023-07-26"
previous_close="6.00"
change="-0.03"
change_percent="-0.5000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="14"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="86"
Volume_recent_avg="131395"
Change_recent_avg="0.01"
Delta_recent_avg="0.79"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="86"
Aroon_momentum_negative="14"
image_negative_thumbnail_id_1="1111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0144.jpeg"
image_negative_thumbnail_id_2="131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0045.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="948"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0110.jpeg"
image_positive_thumbnail_id_2="668"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
